DNTH insider Adam M. Veness plans Rule 144 sale of 16,167 shares
Rhea-AI Filing Summary
A shareholder associated with ticker DNTH filed to sell common stock under Rule 144. The filing lists 16,167 common shares with an aggregate market value of $1,760,909.64, to be transacted through Morgan Stanley Smith Barney LLC Executive Financial Services on 08/10/2026 on NASDAQ. The shares relate to an exercise of stock options for cash from the issuer on the same date. Over the prior three months, 10b5-1 plan sales by Adam M. Veness included 3,833 shares for $424,317.70 on 08/07/2026 and 30,000 shares for $2,424,033.00 on 06/17/2026.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold: 16,167 shares
Aggregate market value: $1,760,909.64
Recent 10b5-1 sale 1: 3,833 shares for $424,317.70
+2 more
5 metrics
Shares to be sold
16,167 shares
Common stock covered by Rule 144 sale on 08/10/2026
Aggregate market value
$1,760,909.64
Value of 16,167 DNTH common shares in Rule 144 notice
Recent 10b5-1 sale 1
3,833 shares for $424,317.70
DNTH common sold on 08/07/2026 under 10b5-1 plan
Recent 10b5-1 sale 2
30,000 shares for $2,424,033.00
DNTH common sold on 06/17/2026 under 10b5-1 plan
Planned sale date
08/10/2026
Date of Rule 144 sale and stock option exercise
Key Terms
Rule 144, 10b5-1, Exercise of Stock Options, Executive Financial Services
4 terms
Rule 144 regulatory
"A shareholder associated with ticker DNTH filed to sell common stock under Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
10b5-1 regulatory
"10b5-1 Sales for ADAM M VENESS 7 Times Square, 43rd Floor New York NY 10036"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Common | 08/10/2026 | Exercise of Stock Options | Issuer"
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the DNTH Rule 144 filing disclose about planned stock sales?
The Rule 144 filing for DNTH discloses a plan to sell 16,167 common shares with an aggregate market value of $1,760,909.64, expected to trade on NASDAQ on 08/10/2026 through Morgan Stanley Smith Barney LLC.
What recent 10b5-1 plan sales are reported for DNTH insider Adam M. Veness?
Adam M. Veness reported 10b5-1 sales of 3,833 DNTH common shares for $424,317.70 on 08/07/2026, and 30,000 shares for $2,424,033.00 on 06/17/2026, reflecting pre-arranged trading activity under a 10b5-1 plan.
Which broker is handling the DNTH Rule 144 stock sale?
The Rule 144 sale for 16,167 DNTH common shares lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker handling the transaction.
Who is the selling security holder named in the DNTH 10b5-1 transactions?
The 10b5-1 transaction section identifies Adam M. Veness, with an address at 7 Times Square, 43rd Floor, New York, NY 10036, as the person associated with recent DNTH common stock sales under a 10b5-1 plan.